411 related articles for article (PubMed ID: 18236392)
1. Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course.
Campsen J; Zimmerman MA; Trotter JF; Wachs M; Bak T; Steinberg T; Kam I
Liver Transpl; 2008 Feb; 14(2):181-5. PubMed ID: 18236392
[TBL] [Abstract][Full Text] [Related]
2. Recurrence of primary sclerosing cholangitis in patients after liver transplantation.
Ołdakowska-Jedynak U; Nowak M; Mucha K; Foroncewicz B; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Patkowski W; Górnicka B; Paczkowska A; Michałowicz B; Pilecki T; Pawlak J; Krawczyk M; Paczek L
Transplant Proc; 2006; 38(1):240-3. PubMed ID: 16504713
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal.
Campsen J; Zimmerman MA; Trotter JF; Wachs M; Bak T; Steinberg T; Kaplan M; Wright F; Kam I
Liver Transpl; 2008 Sep; 14(9):1281-6. PubMed ID: 18756454
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
5. Prediction of graft loss and death in patients with primary sclerosing cholangitis.
Kornasiewicz O; Lewandowski Z; Dudek K; Stankiewicz R; Nyckowski P; Krawczyk M
Transplant Proc; 2009 Oct; 41(8):3110-3. PubMed ID: 19857688
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.
Graziadei IW; Wiesner RH; Marotta PJ; Porayko MK; Hay JE; Charlton MR; Poterucha JJ; Rosen CB; Gores GJ; LaRusso NF; Krom RA
Hepatology; 1999 Nov; 30(5):1121-7. PubMed ID: 10534330
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.
Wiesner RH
Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):667-80. PubMed ID: 11492975
[TBL] [Abstract][Full Text] [Related]
8. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
9. Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma.
Wu Y; Johlin FC; Rayhill SC; Jensen CS; Xie J; Cohen MB; Mitros FA
Liver Transpl; 2008 Mar; 14(3):279-86. PubMed ID: 18306329
[TBL] [Abstract][Full Text] [Related]
10. Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis.
Gossard AA; Angulo P; Lindor KD
Am J Gastroenterol; 2005 Jun; 100(6):1330-3. PubMed ID: 15929765
[TBL] [Abstract][Full Text] [Related]
11. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.
Kugelmas M; Spiegelman P; Osgood MJ; Young DA; Trotter JF; Steinberg T; Wachs ME; Bak T; Kam I; Everson GT
Liver Transpl; 2003 Jul; 9(7):727-32. PubMed ID: 12827560
[TBL] [Abstract][Full Text] [Related]
12. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.
Alabraba E; Nightingale P; Gunson B; Hubscher S; Olliff S; Mirza D; Neuberger J
Liver Transpl; 2009 Mar; 15(3):330-40. PubMed ID: 19243003
[TBL] [Abstract][Full Text] [Related]
13. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group.
Okolicsanyi L; Fabris L; Viaggi S; Carulli N; Podda M; Ricci G
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):685-91. PubMed ID: 8853259
[TBL] [Abstract][Full Text] [Related]
14. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
[TBL] [Abstract][Full Text] [Related]
15. High lifetime risk of cancer in primary sclerosing cholangitis.
Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR
J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of primary sclerosing cholangitis after living donor liver transplantation.
Tamura S; Sugawara Y; Kaneko J; Matsui Y; Togashi J; Makuuchi M
Liver Int; 2007 Feb; 27(1):86-94. PubMed ID: 17241386
[TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis.
Tanaka A; Takamori Y; Toda G; Ohnishi S; Takikawa H
Liver Int; 2008 Aug; 28(7):983-9. PubMed ID: 18397233
[TBL] [Abstract][Full Text] [Related]
18. Liver retransplantation for ischemic-type biliary lesions after orthotopic liver transplantation: a clinical report of 66 cases.
Zhu ZJ; Rao W; Sun JS; Cai JZ; Deng YL; Zheng H; Zhang YM; Jiang WT; Zhang JJ; Gao W; Shen ZY
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):471-5. PubMed ID: 18842491
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.
Alexander J; Lord JD; Yeh MM; Cuevas C; Bakthavatsalam R; Kowdley KV
Liver Transpl; 2008 Feb; 14(2):245-51. PubMed ID: 18236405
[TBL] [Abstract][Full Text] [Related]
20. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation.
Nashan B; Schlitt HJ; Tusch G; Oldhafer KJ; Ringe B; Wagner S; Pichlmayr R
Hepatology; 1996 May; 23(5):1105-11. PubMed ID: 8621141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
